School of Food and Biological Engineering, Hefei University of Technology, Hefei 230009, P. R. China.
Women's Hospital of Nanjing Medical University (Nanjing Maternity and Child Health Care Hospital), Nanjing 210004, P. R. China.
Anal Chem. 2022 Sep 27;94(38):13076-13083. doi: 10.1021/acs.analchem.2c02283. Epub 2022 Sep 15.
CRISPR/Cas-based systems are highly attractive for developing next-generation diagnostic technologies because of their intrinsic merits such as simplicity, sensitivity, and specificity. However, currently, nucleic acid amplification procedures are still needed to achieve attomolar sensitivity in most CRISPR/Cas-based assays, which causes high cost, operation difficulty, and low efficiency. Herein, we combine the CRISPR/Cas12a-based assay and a single-microbead detection platform for one-step and amplification-free detection of DNA at the single-molecule level. By modifying DNA reporters on a biomimetic membrane-coated microbead, the activated Cas12a by targets will cleave these reporters and lighten the bead within 10 min. The method allows the detection of the target down to three copies in a 5 μL sample. Furthermore, we successfully apply this method for the specific identification of viral infection, foodborne bacteria, and DNA mutation in real samples without extra nucleic acid amplification. We believe that this approach offers new insights for developing CRISPR/Cas-based DNA assays in biomedical applications.
基于 CRISPR/Cas 的系统因其简单、灵敏和特异等固有优点,非常适合开发下一代诊断技术。然而,目前大多数基于 CRISPR/Cas 的检测仍需要核酸扩增程序来实现皮摩尔级灵敏度,这导致成本高、操作难度大、效率低。在此,我们结合基于 CRISPR/Cas12a 的检测方法和单个微球检测平台,实现了在单个分子水平上一步法和无扩增的 DNA 检测。通过在仿生膜涂层微球上修饰 DNA 报告分子,被靶标激活的 Cas12a 将在 10 分钟内切割这些报告分子并使微球变亮。该方法允许在 5 μL 样品中检测到低至三个拷贝的目标。此外,我们成功地将该方法应用于实际样品中病毒感染、食源性病原体和 DNA 突变的特异性识别,而无需额外的核酸扩增。我们相信,这种方法为基于 CRISPR/Cas 的生物医学应用中的 DNA 检测提供了新的思路。